AC
VRTX icon

Apella Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Apella Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
+603
New +$267K ﹤0.01% 572

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Apella Capital's VRTX Position: Q2 2026 in Review

Apella Capital opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 603 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #572 among its holdings.

252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Apella Capital held 603 shares of Vertex Pharmaceuticals worth $315K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Apella Capital position in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Apella Capital's portfolio in Q2 2026, its #572 holding.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.